A rare case of silent pituitary macroadenoma with positive TSH and prolactin immunostaining
Department of Endocrinology, Diabetes, Metabolic diseases and Nutrition, Mohammed VI university hospital of Marrakech, Faculty of medicine and pharmacy of Marrakech, Cadi Ayyad University, Marrakech, Morocco.
Case Study
World Journal of Advanced Research and Reviews, 2022, 14(02), 112–114
Article DOI: 10.30574/wjarr.2022.14.2.0419
Publication history:
Received on 04 April 2022; revised on 06 May 2022; accepted on 08 May 2022
Abstract:
Silent thyroid stimulating hormone (TSH)-immunostaining pituitary adenomas are rare tumors, they can be either pure or immunoreactive to other pituitary hormones. We report a case of a silent macroadenoma with both TSH and prolactin immunostaining but with no clinical manifestations of hyperthyroidism or hyperprolactinemia. Pituitary magnetic resonance imaging revealed a macroadenoma. Transsphenoidal surgery was incomplete. The immunohistochemical staining showed that tumor cells were reactive to TSH (60%) and to prolactin (40%). Control pituitary imaging revealed a residual macroadenoma, and dopaminergic agonist treatment was administered. Mixed TSH and prolactin pituitary adenomas are rare and usually diagnosed incidentally or in the face of compression signs. Hormonal examinations for all patients who have a pituitary adenoma should be performed even in the absence of symptoms of hypersecretion. Pathological examination with immunostaining is key to diagnosis of clinically silent pituitary adenomas. Complementary therapies can be used when surgery is incomplete or contraindicated such as dopamine agonists and somatostatin analogs.
Keywords:
Pituitary adenoma; Silent; Thyrotropin; Prolactin
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0